0000950103-12-005035.txt : 20120928 0000950103-12-005035.hdr.sgml : 20120928 20120928100421 ACCESSION NUMBER: 0000950103-12-005035 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20120928 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120928 DATE AS OF CHANGE: 20120928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 121114802 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: R924 8EP BUSINESS PHONE: 441256894000 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: R924 8EP FORMER COMPANY: FORMER CONFORMED NAME: Shire Ltd. DATE OF NAME CHANGE: 20080523 FORMER COMPANY: FORMER CONFORMED NAME: Shire plc DATE OF NAME CHANGE: 20051125 FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp33199_8k.htm FORM 8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): September 28, 2012

Shire plc
_________________________________________________________________________

(Exact name of registrant as specified in its charter)

Jersey, Channel Islands
_________________________________________________________________________

(State or other jurisdiction of incorporation)

0-29630                                                  98-0601486
(Commission File Number)                (IRS Employer Identification No.)

5 Riverwalk, Citywest Business Campus, Dublin
24, Republic of Ireland
_________________________________________________________________________

(Address of principal executive offices)                              (Zip code)

Registrant's telephone number, including area code               +353 1 429 7700
_________________________________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
 
Item 8.01.    Other Events

Shire plc has issued the press releases attached hereto as Exhibits 99.01 and 99.02 which are incorporated by reference herein.


Item 9.01.    Financial Statements and Exhibits

(d)  Exhibits.  The following exhibits are filed herewith:

99.01          Press Release dated September 28, 2012

99.02          Press Release dated September 28, 2012

 
 

 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
SHIRE PLC
 
     
     
 
By:
/s/ A C Russell
 
    Name: Angus Russell  
   
Dated: September 28, 2012
 
 
 

 
 

 
EXHIBIT INDEX
 
Number
 
Description
99.01
Press release dated September 28, 2012
99.02
Press release dated September 28, 2012
 
 

 
EX-99.1 2 dp33199_ex9901.htm EXHIBIT 99.1
 
Exhibit 99.01
 
Press Release
www.shire.com
 
 
 
 
Purchase of Shares by Employee Benefit Trust

September 28, 2012 – Shire plc (LSE: SHP, NASDAQ: SHPG), announces that the Shire Employee Benefit Trust (the "Trust") has been requested to purchase up to a total of £30 million of Shire plc Ordinary Shares over the period September 28, 2012 to November 30, 2012.

Any such purchases will be made for the benefit of the Trust, in connection with Shire's management of its various employee share schemes.  Any purchases have been requested to be made on an irrevocable, non-discretionary, rolling basis.

 
For further information please contact:

Investor Relations
   
Eric Rojas
erojas@shire.com
+1 781 482 0999
Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157


Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:

 
·  
Behavioral Health and Gastro Intestinal conditions
 
·  
Rare Diseases
 
·  
Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 

EX-99.2 3 dp33199_ex9902.htm EXHIBIT 99.2
Exhibit 99.02
 
Press Release
www.shire.com
 
 
 
 
 
PDMR Share Dealing

September 28, 2012 – Shire plc (LSE: SHP, NASDAQ: SHPG), announces that Ms Tatjana May was granted today, under the Shire Sharesave Scheme, an option over 579 ordinary shares at an exercise price of £15.54 per share.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure and Transparency Rules.


Tony Guthrie
Deputy Company Secretary


 
For further information please contact:

Investor Relations
   
Eric Rojas
erojas@shire.com
+1 781 482 0999
Sarah Elton-Farr
seltonfarr@shire.com
+44 1256 894157


Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients’ needs, we develop and provide healthcare in the areas of:

 
·  
Behavioral Health and Gastro Intestinal conditions
 
·  
Rare Diseases
 
·  
Regenerative Medicine

as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for patients, physicians, policymakers, payors and our shareholders.
 
 
 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
 
 

GRAPHIC 4 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(" M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@," M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$! M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,` M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I M*C0U-CH.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#P`OP,!$0`"$0$#$0'_V@`, M`P$``A$#$0`_`/W\H`*`"@!/;_ZU`;=`Z=.,?UHVT6X?@>(?%WX\>#OA%;QP MZD\NJ>(+J(RV/A_3V3[4R=%GO)&.VQM2W1WY;'RJ>:^FX?X6S'B"H_J\?8X: MF[3K23Y5?I%+=_@NK/DN)>,,LX;IVK2]KBI*\:,6E+UEV7ENSX=UO]L7XL:S M>-#XE]E*+YOG*Y@G]JGXY:5(T%YK.ER3;6#0W M&CV+20$Y^^L!7RY5S]QCD$88<&NU>'G#=1*5.G52\IM'!_Q$CB?#MPE5A==' M=O\`,D\*?'3Q5XJUQ;/XA_%OQIX1L+MTCM[_`,,06=K96[R-M(OA;B.6V@Y' M[U/,V]2,,IPEKW3W-G"E3YH:N$X1C'7?IZ,_5:.&SC**V"Q6%S:KFV68F<8U%7JU*TX MQDK\T'.PU/4[&/P?X;>.QU+4+*-VO-05G2SO)K9'8!< M!F6,$XXR37VV%\,L!7PV'K/&54ZM*G-I.*2*V8X?$XFC'"T MN6A4G!7B[VC)QUU\C[-^"7Q!U'XG?#_3?%VJ6-IIMY>W>I6[VEC)+);HME?3 M6L;*TP#%F6,,<]S7YIQ'E5+)&:&'JX>E&HZU[\RNEK;NCQ[X2?M6^+?B#\0_#G@[4?#&A:=9:S->1S75 MI=7LES"+;3KN]4Q)(H0EGMU4[NS&OH^(^`<)DF48G,*6)JSG0Y+1DXV]Z2B] MHI]>Y\OPQXBX[.\ZP>6U48M-6BY::^1]W#_`#VK\LV\K'[%MIV% MH`*`"@`H`*`"@`H`*`"C;R`*`$^GX=J6WE8+6/-_B1\4?"7POT:74?$6I107 M,D<@TO2HOWNHZE<[3Y4-M:1_.RF0J&D("+GDYP#[&3Y+CRW9X6=Y_@WL]%T:1E-I8)"4C6YN-D:* M`=I)&[]RP>94<%1I9)PYA5C*V'2A4J)\N'I.VKG56\KZ\JO)];'\]8[+:^+K M5L[XBQ#PE.O)RA2;_?2UTM3=K1MN]CZ2^$/P%TCQYX4M/$3_`&KP5X5U99#I M>DZ)-'+XCU>QCD:%+[Q#XEGC:96E9&(L[-(80/O!C@U\5GW%F+RO'3PL)K%X MNBDJE25X0I3>KA3A%V:75R;>NCW1]YPUP7A)/V)O`EW93'PSKNO:-J01FMVO9HM2LGE`^5;F)XHW5&;&YT?<` M20":Y<#XEYK0J1^M4*=>E=#2ZVW5SNS#PIRNM1G]3Q,Z%:*O&Z5F^TG> MZ3[GYR^*/#>I^$/$.K^&-9A6'4M%O);*Z13NC9DY26)OXH9(V5U/HPK]LRS' MX?-,%0QF'=Z5>*?HWNK>3T9^#YGEU?*,=6P5>+IU:$FFMNMD_GN?H!^QKXOD M\1Z!J_@36V:]7PC>V&MZ!Y[NS6]M-+*?*4[N8[6]17C5LA?/``PHQ^->)&50 MP&-I9AA8*G'&)TZMM+SWNETO&]VO(_;_``NS:6.PE7+,3)U)8*7M:7,_ACHK M?B?GMKO_`"'M?_[#VM>W_,4NJ_9LK:679?;1?5Z/_IN)^'9I99EF&EG]9KZ= MOWDC]7_V1N/@EH';&I:_CVSJ]W7\]\>?\E'BK*WNQT^\_I7PX_Y)JA_CE^43 MZ/:\M(I!$]S;I)SB-IHT?CKA2P)Z^E?(*C5Y>:-*7*NJB[?@?:2QF$IRY)8F ME"?\KG%/[KEA64@%""O8J01^!%9M-:6Y;=-CHC*+5X-./1IZ?@>+?&;X+:7\ M9++1++4];O\`1$T2[N+N*2PM[>=IVN81"R2"X("J`,C;^-?1\.\28CARM6K8 M;#PKNLDFIMI*U]N7U/E>)^%<-Q-2HTL1BIX6-#;DBG>[OK=H\W^'?[)OA[X= M^,M$\967B[6M2N=$DNI(K*ZLK&*WF-U97-DPD>)MZ!5N688[J!TKVLZX^Q^< MY=7RZM@J-&G7Y;RA*?,N62DK)Z=#P\B\.,OR+,\/F=#,*U:IAN9QA*$(Q]Y- M:M._4^LNG3MT_&O@K6V/T:Z7^0O3_.*-O*PRN]U;1,(WGACD8X5'E1&8XSA5 M)!)^E6J51Q;C3ERI:M)V7^1A+$X:G)0E7IPGLHN<4[^E[EC]/TQFHV\K?@;K MRVZ$,L\-N,RRQQ#KF1UC`'<_,151A-_PX.3\D95*]"A_%JPI?XI*/YB0W-O. M`8)X901D&*1'!![@H3Q[TY4ZE)M3IRIN/1IJPJ>(P]32C6A/_#)/\F3U!L'T M_"@-O*P4`)_GZ4:?=\@VV#I[?I1:V@;?(^:_BI\=SH6K1_#[X:Z=_P`)C\2; M\F!+&VQ)8:$T@_X^=4E4A-\8.\Q%U"@9E91P?K\EX9]O1_M/-JGU#*J?OM_9.24_KN:SO&T=8TF]+RZ-]=]#)\(?`.^TV M/4_B!X\U"/QS\6)]/NKG39M34W&B:#J`MY)+*UL+%L(XBN-B[]J@`?NU7[QW MQW$M*ZZ+F:VO#=$J;5X) M6B>SA@X6U@B92BQ(J@`>O7]ZR?`X'`X&A#+Z<:=&4$TXV]ZZNVVMWY[L_GK. M<9CL7CJ\L?4DZT)R7*[I12>BBNB\CZO^"/[5D'@#PYIG@OQ=H=S>:1I*M;Z; MJVE-']JMK1I&D$%W92;1<;&D;;)&X.#@CBOS[B;P]J9ABZV89=75.I5]Z=*= MVI2MJXM;7T\NI^D<)>)%/*<'1RW,,.YTJ.D*D6DX1?1[W7^9]H^%OVA/A%XL M6-=.\8Z=:74@&;#5]^DW4;'HA^V*D3M_USD>OS/&\)9_E_,ZV7U.2'VH6E'Y M6=_P/U;+^-.',P451S"$*C^Q).+5_E;\2KXG^`OPC^(>M7/BW6=)74]1U*.V M$U[9:KY-0C@ZIX/TB73;V_M%L;N M1[Z[N@]L)DG"!)Y&53YL:GF6 MY?;_`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`1 M%7@`#'%>ID&1Y56R?`5*F`HRG*E%R;A&][+78\GB#/\`.:&([Z5KR]TFPDNV%E;VS MW&X&\DBW,';<(T`P-QX\9\"X3%<0XC&8BC&GEM.%+V5&"Y8SDE[W,ET3Z=>I M[D?$#&X+AO#X##UI3S&48.W*HO=/>[/G.QUK5M6\4Z/?:IJNH7][ M+K6FN]S>7T\\S,U]"3\SR$CDG@8'/2OJ\;E^6X;+<5"EAJ5-1I2LE&*MIV/C ML!F.9XC,\).MBJTN:K%ZREW/T1_:!_:8E\!R?\(5X&-O/XH2UB_M;5IE$UOH M7FQ!DMXHC\L^IE2&(;*1@C<"QP/R3A/@C^UG+,,PO3P//+V<%HZEI/6_2/EU MW/V3B[C[^QZ-'+LK:EC?90YZFZIWBM+?S>?<_/C4=>\=>/-0=K_4_$GBC4)" M9&A62^OF7)R2EK;`I"F3P$C51VK]>IY?D>4TH06&P^'II63<8Q>GW'XU/,<_ MS6LY?6,37E)W:4I-*_:VQ7M=1\9^"=0CDM;SQ'X6U&,B1%,E_IDQP>"89-@D M3C^)64]QBK6"R3,:4HJAAJ\=4[1BVKF?UW/LJJJ4L1B<+*+NKN<4?H+^SE^T MO>>+]0M_`GCZ6'^WID*Z'KJHL"ZN\:EGLKZ)`(X[_P`L;D=`JR[6&`W7\BXS MX(CE5.6996F\(OXM+K3_`+T?[O==-UH?M'`O'L\SJ0RO-9)8G14JNW/_`'7Y M^;^;/N&OS#;3:Q^NA0`G^?3%'IH&UNA\>_&SXUZY<^((/@Y\(A]N\:ZM)]CU M75[9@T>@1R#,T44JY6.\2(EY9F.V!<_\M"`OW_#G#>'IX66?9[^YR^A[U.G+ M1UGT;3U<7T2^(_,N*>*<35Q<>'>'U[3'UWR5:L=523W2:V>]SUCX-?!C0_A/ MHYVD:IXKU-1-XA\1W`+W5YU?3 MCT'3WKYW;RL?5;>5CX_^-O[*VF>/[^Z\4^$+R#P]XGN29=0M;B-CH^KR!3^^ MD6(;K.];`#2H&5NK+GD_H7#''>)R:G#!8R#Q."CI%KXZ2?1)V37;6Z\S\PXL M\.\/G-2ICLN:PN->LHNRA4;ZWZ/\#X-\6?`OXJ^#'F_M;P=J]HEQS^]2,U^MY=Q?D68*/LL;"C/^2HU"7W.S^X_&J5CR>6)[>0Q3Q/!+&2#%,C12(><@HX5@?PKZ.%2A7BITI MQJ0?:S1\W.E7PDN6I"="<>CO%H[/PC\1?&_@2[CN_"WB34M+,;AVM5GDFTZ? M_9N-/F9H95(X/R@XZ,*\K,N'\JS2FX8O"0;LTI**3C?JFK-,]7+.(K"I M@\94@HN[CS73\M;Z,_4C]GWX\VOQUKVQ_Q-+JOZ%RO3+<`M MK8>C_P"FXG\SYG_R,LP6W^TUK?\`@R1^A_[&GPXT0>%;[X@:CI]M>:Q?ZI=: M?I<]S$DWV#3[#RT=[42*?)FENFF#.OS;8E`."<_C?B1G6*>84\LI594L/2IQ MG)1;CS2=U9VMI9;;.Y^X^%V0X/\`LZIFE>C&IB)S<(.2348JST3TOJ?3/Q:\ M"Z'XV\!>)-)U+3[626/2;^[TRY,,8GLM1MK:2:UN()@NZ)O.10VTCG9GWW$F38',,GQU&KAX1<*4YPD MHI.,H1)=,\S'_`*^L]D_9K^!]G\5]9U'4O$1G3PIX>:!+BWMY M&@DU74)P7CLO/7F*WCB4/*5^9MZJ",DCYKCCBFKD-"EA<$U]?H?5<`<(TL^Q%7$8U-8+#6;CM[1NZY?(^]?%OPV^$W@+P1K_B"W\! M^'8U\,Z/>:M;DV*/,+C3[=IK9A/(3(TGG(F"6))]Z_)9IF.%PE3,:K6 M+JPIR6EN64O>TM:UKG[+F>09!DV4XO&4LMI1E@J,IP>MU)+1[[W/QXO[V\U. M^O-1O93-?:C=2W=S-*Q)>XN93([,Q).T,_<\`8[5_2%"E'!X2%*E#E5"FE:. MFJ7;SMT/Y>KU7BL7*I.32JSW?V8R?Z'ZL?!W7_@5\,_!>D:39^-/!L>K2V5O M%\7PGDN586C''86.(<%*K*4H\SF]]6KJW9$?Q MH\0_!#XD^!=:TF7QKX.DUBWLKB]T&\74;+[9:ZE:QM/`D$@8/MG9!$T8.'#X M(/%/AO"<2Y-F>&K4\!B8T)34*L>5\KA)I-M7M>-[W\@XIQ7"N&YMI4FC9< M'H'4<=QQT-?O^)P]/%86K0JP3IU(-.+VV/YQPE>>"Q5*O1ERSI3336EM?\C] MV_!.OIXH\(^&_$4>`-8T:PU`@=%DN+='E4?27>/PK^4%:M["I** M6VE[Q_\`)6C^Q,GQBQ^68+%K_E[35_\`%%N$OOE%G45Q'I'SE^TG\73\+?!; M1:5,J>*O$?G6&BC@FSB51]MU1DSG$$;@)V,LB>G/V'!G#[SO,HNK&V#PC4ZO M9O>,/25G?RTZGPW'?$BR#*Y4Z,K8W%IQI):.,7I*2\]=#D/V3_A8OAOPLWQ` MUN-IO%7C-6NUN;O=)4_&+XE-\)_!TGBP:.VMK#J%E926:7`M"B7;.OG>88W`"LJC&.=_ M6O;R#)_[;S&G@(UEAW43:DU?;I;YGSW$N>KA[+IX]T'7C!I.*=M^I\J0_MRP M--#')X!FBCDFBC>3^V8OW:22*K.1]F&0H8G&>U??UO"VM1I5)PS&,G!-J/): M[70_.:'BY1J5J=)Y9*"G)*_.K)/J?>]I<17MG;7<+!H+NWAN(B,%6BGC65", M<$%6'/O7Y35IRH5:E%^[*C.47ZQ;3_(_8*%2&(P]*JDN2K3C-+=6DD_U.0\3 M_#7P'XQ@>#Q'X5T74BZ[?M,EC!'>IG/^KOH56>/GG"R`9ZBN_!YSFF`G&6%Q MM:GR[1YY.'IRMVM\CS<;P_D^.IRIXK`47S7O*,(QFK]I)7/RT_:.^#>G_"+Q M/IJZ%<3R^'O$-O=7.GV]V_F7-A-:O&MU9M+@&:$":)D=ANPVTY*Y/[SP/Q)7 MS[!UHXJ*CB,(TI2BK1DGLTNC[G\[\>\+4.&L=1^J2?U7%W<(OXHM;IO\O(I_ MLPZE=:9\;/!ZVK.J:@]]IMU&N=LEM<64I8.,C*HZ*_L5!Q6G'M"E6X'2TDU8R\.Z]6AQ-@8TVU&M)0E;^5[GB^O<:_K_;&O:U[?\Q2[KZ?*URY; MEZV_V>CY?\NXGR>:)+,\QZ?[37_].2/U?_9&X^"6@?\`82U_V_YB]U7\]\>Z M<18GI:,?U/Z4\-TEPU0M_/+[^6)]`>(O^1?US_L$:E_Z1S5\O@/]^P?_`%_I M?^EQ/L,S_P"1=CO^P>K_`.D2/P-DXDF[?O9OP_>/7]9T/]WI_P"!?D?QMB?] MYJ_XW^9]7_%O_DW7X`_76/YW%?G/#?\`R6?$?^*G_P"D'Z3Q-_R1?#7_`%[G M_P"G&<+^S+_R7+P'_P!?6K?^F'5*]SCW_DELQ_[A?^G8GB>'G_)699ZU/_3< MCS_XF?\`)1?'/_8U:U_Z72UZW#?_`"(\N_Z]1_)'C<2_\CS,?^OK/T7_`&+; M>*+X4WLZ(%EN/%6J>:V.6\F.WCCS]%&*_%_$J3_U@4;Z1HPLNU[_`)G[IX4Q MBN')22LY5I7^7_#GKG[0%O-/\&?B)'!N#)X4CY]NE?.\ M*SC2X@RIR]U>WBOF[I?BSZ?C&$Y\-9LH+X:$W;R6Y^*JC[HR%!*C<>%7<<`G M'11G/YU_452480E/I%-Z>6I_)%.'-.$$[.3C%?/0^L[']C;XEZA96E];:IX1 M^SWEM!=P$WE[N,5Q&LJ9Q8$9VN.AK\WK>)N68>M4HO!UKTIRB]EK%M/J?J&' M\+,VQ&'HUX8JCR5X*:]&KHM_\,5?%$=-3\(C'_3Y?=_^X?62\4LKC_S!UK?] MN_\`R1LO"7.-OK-)=@_X8K^*?_05\)?^!M_Q_P"2%)^*.5V:6"K?AU^8+PFS ME-?[52_K4_1#X6>&-1\%_#WPIX5U:6WEU'0]+2RNI+1WDMFD6:9QY+R(K&/8 MZ@94=.E?D.>8^EF>:XO'4(.E3Q#@XQ=DURTX0=[=Y1;^9^W<.Y=5RC)L%EU: M:G5PRJ*36WOUJE16^4TCOZ\D]H_*/]LG4+RY^+J6%WYJ6&E>'])2Q7L8;S?< MWDT0Z;FF+Q_6`9K]W\/L/3I<.5JM!KZQB%5<^\91J5(07E>,8OYG\Z>).(J2 MXJI4:]XX7#2H\E](\LJ-&<__`":4C]//"TVG3^&M!ETB2&33&TC3_L+VY!A- ML+6(1"/;P%"`#';XGCXUH8W%1Q$7&O[6ISIZ/FLHE0EEF!> M%DG15&FHM/2W*M/4WQ^7Z>]=?%3P9#\0_`?B7PAOBCNM0T] MVL'?'[C4+<_:+"5QU6/[3&BL(H34Z52*<7%Z:H_DC&X&OEV*J MX6O3=*K1DU9JST9]5L&:ZE?#.^ M`.`%`4"OU?AKAO#<.81T*,G4JU'S5)O1R?HM$ETL?CW%'$V)XEQJQ%:"HTJ2 MM3IQ;M!?/6[W?F>\?L;_``[OM7\:3^/[JW>/1?#5O<6MA/(I5+S5[V(PNL!/ M#K;VS2,[#.&D0=2G-4Z6^3N?(^O?\A[7^W_$^UKV_YBEW7Z-E6F6Y?II]7HV_\%Q/ MS',_^1EF/3_::_EO4D?J_P#LC?\`)$M`QQ_Q,M?]L?\`$WNJ_GOCS_DHL3T] MV'ZG]*^&Z_XQJAT_>2_*)]`>(O\`D7]<_P"P1J7_`*1S5\O@-,=@^EJ]+_TN M)]?F>F78[_L'K?\`IN1^!L@Q)-V_>S>V/WCU_6=#_=Z:V]Q?D?QKB=,16T^V MU^)]7_%O_DW7X`XXP=8]NK7%?G/#?N\9<1_XJ?\`Z0?I/$W_`"1?#73]W/RM M^\9PO[,O_)WQ[_R2V8]$O9:?]Q8'B^'FG%F6=-:G_IN M1P'Q,X^(OCC_`+&G6O\`TNEKUN&],DRY;6I1_)'B\2_\CS,?^OK/T=_8PX^$ M\7=:: MG8W5A&08/?:YKX3#5YX2O1KTG[]"<9QZ:Q::/T/&8:GB\+7PM32 MG7A*#])*Q^&WQ"\$:I\//%NL>$M6A>-["YE%G*X8)?:9(S&RO8&P`\17]1Y%FF&SC+,/B:+4KP2G&^L96M)->M_4_D7/\`*<5D>:8C#58.GR3; MINUERMOEL_0^U?@C^UCX=T3POIGA3XB+?VEQHMM'866NVMO)>P75C`H2W%]% M%F:&YC3"%D1PP4'`.<_F7%'A]C:V.KXW*7&=/$2% MX[.YGLY[#2K*1U*BYF>Z5)IFC)W")8@&*\L!7F9-X<9K7KTY9CRX7#0:ZZ7WN?(7@[ MXE_'GQSXHTGPOHWQ`\3R7^L7J1;HYH/+M;=GWW=W(%ML16\$)=SG`&U1GFOT M+-&S*M>K-7MM&-] M;Z:(_8+3K:2RL+*SEN9KN6UM;>"2[N&W3W,D42H\\S`#,DC`LQP.6-?SQ5E& M56I.,53C*3:BMHINZ2]%H?TWAX2I4*5.\_F[ERLS8\9^+'P M-\&?%R&V?7([FQU>PC:&PUO3G2*\@A=M[02JZM'=6^_YO+D4X.2",G/T60\3 M9EP].?U.494:CO*G->[?NOY7WMN?+<1<)Y9Q%"/UJ#IUZ:M"K'1_-+?H>5^% M/V=OB'X#`LO"7QNUG3]&1RT>EW.B6M];H&)8[(9YS'$T%?YG@Y;P9G.3KV>!XAE3H?\^Y0E))=DN:R/8K#X M>^)SM_X2'XH>*M55<;H=.@TKP_"X[JYL;1I=I]I`?>OFJN/PJE?"Y=3H'M*T(/\`V=;O')(`)KB>XN+J MZGP<_O;FYE>1OFR<9`R>!7GUJ]2L_?:23NE%**7HE9(]7#X:EAE:ES=KRDV_ MFV>5_%?X!^!_BN@NM3@DTGQ!#&(K;Q#I@CCO0BY*17<;*8[V%2I[3#7UHS=X^?+_*_32^MCYGB+@W*N((N5:G[#%+:K#1_]O)? M%Z_F?%>O?L4?$2PFD'A[7/#^N6P)\HW+S:3!)&Z2QA\>DF"?2OT_!>)^ M6SC&.+PT\+/2[7-./G\$6_P/R;'>$^;T)R^I5HXN'2SIT[?^#)Q.<@_8[^,S MR!)+;P[:IQF636XG4#C/RPQ.Q/)/2O0J^(_#T(N5.K*H_P"54J\?_2J45^)Y MT/"_B;FY9894X_S>VPSM\E7;_`]E\#_L21074-YX_P#$J7MO&RL^BZ#%);QS M8Y,=QJ,_[SRST(BC0_[7-?*YKXGU:E.5+*L)[!NZ]I4:=K]HK]7\CZ_)O">G M2J0JYKBO:1C9^R@K/T(Q-5U*U1WE*6_P#P%V2V/U_!X+#9?AZ> M%P=&-"C25HQBK?-VW?=GY^:C^Q'XFO-1U&]3QQHL:WNHW]ZB'2[PF-;R[FN5 M1B)^642A21U(S7ZYA?$[#8;"X?#_`-G5&Z%.$+\T5?DBHM^6Q^*XOPFQ=?%8 MFO',H0C7JU*B7)MSR?"WP%IW@^]U&WU2XL;K4;AKRUADMX M7%]>S72JL4K,P*B7:>>2*_..(097 M3R^=55I0DY(.0.2`7S@5Y. M'J*AB*%:VE&I&=MOADI6^=CVL51=?"XBA%\KK4YP3[<\7&_RN?G2W[#?B\;V+8_X^/>OV"GXHX:%*%/^S:GNJU^>)^(U?"/&3J3FLR@ ME*3DER=]>Y[%XS_9GUKQ-\,OAQX#@\3:;:77@?[;]IOY+&X>"^^UF4KY$*RA MHMN\9W$]*^9RWC.CE^=YGFKP7 M1DG-QTE>3EL<]\*?V3M>^'?C_P`/>,;OQ;I6H6VB37DDEE;Z?=033BZTZ[LE M"223%4(:Y5CDAQ#Q_0SK*<3EL,#.A*MR6FY*RY9J6J6O0X.&O#?$Y# MG&%S.>.A5AAN:\%&S?-%K373)M?UV'QIH]M%K&KW^I1P2:; M>-)`EY.IT'AH\D8J<,Y7_9]2 MNJ[YY3YHKE6O2Q[/T_SBOF[6\CZG8\G^*?P;\'?%C34M/$%J\&HVBN-,URRV MQ:EIY;)*I(01-;%CEH9`RD\\'FO=R/B',,@K^TP=3]T_CI2^"?RZ/S/F^(.% M\MXAH.GBJ?)6BOM<:5=;.= MHE41S1[\8R5;!/85^J8/Q/R^48K%X6>&DEJU>:OY$V:4)R^I5X MXF%]-84W;S]I.)4T?]BKXEW)V5TXOZMAZE>=G96<%?SYDOR,L'X3YS.:6)JQPL.KYJ<_72%23/MWX0 M_`KPA\(;21]+634M?NXEBU#Q!?*@NY4!W&WM8U^6SM=W/EIR3RS-7Y?Q!Q/F M'$%7]^_98:#O"C%^ZNSEMS-+RLNQ^O<-<(9;PU2_<1]IBI*TZS5GY\J^RF>V M5\T?6!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`% $`'__V3\_ ` end